HSPG2 and neoplasm: In our experiments with U73122, a commonly used broad-spectrum PLC activity inhibitor, the suppression of broad PLC activity inhibited the cell viability of some GSCs, even at concentrations that did not affect the normal fibroblast cell line, IMR90, which is consistent with previous findings that were obtained using various tumor cells (Supplemental Figure S1A) [44,45].